Tyra Biosciences Inc (NASDAQ: TYRA) on Monday, plunged -7.13% from the previous trading day, before settling in for the closing price of $10.94. Within the past 52 weeks, TYRA’s price has moved between $10.65 and $29.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 4.06%. With a float of $32.05 million, this company’s outstanding shares have now reached $52.87 million.
The firm has a total of 49 workers. Let’s measure their productivity. In terms of profitability, gross margin is 30.28%, operating margin of -19938.65%, and the pretax margin is -16681.27%.
Tyra Biosciences Inc (TYRA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tyra Biosciences Inc is 39.39%, while institutional ownership is 60.09%. The most recent insider transaction that took place on Feb 05 ’25, was worth 74,324. In this transaction Director of this company sold 5,401 shares at a rate of $13.76, taking the stock ownership to the 443,885 shares. Before that another transaction happened on Feb 05 ’25, when Company’s Director proposed sale 120,000 for $13.75, making the entire transaction worth $1,650,000.
Tyra Biosciences Inc (TYRA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.57% during the next five years compared to -102.86% drop over the previous five years of trading.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Tyra Biosciences Inc (TYRA) is currently performing well based on its current performance indicators. A quick ratio of 29.55 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.61, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -2.01 in one year’s time.
Technical Analysis of Tyra Biosciences Inc (TYRA)
Analysing the last 5-days average volume posted by the [Tyra Biosciences Inc, TYRA], we can find that recorded value of 0.41 million was better than the volume posted last year of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 10.45%. Additionally, its Average True Range was 0.79.
During the past 100 days, Tyra Biosciences Inc’s (TYRA) raw stochastic average was set at 0.69%, which indicates a significant decrease from 3.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.80% in the past 14 days, which was lower than the 72.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.78, while its 200-day Moving Average is $18.00. Now, the first resistance to watch is $11.29. This is followed by the second major resistance level at $12.42. The third major resistance level sits at $13.06. If the price goes on to break the first support level at $9.53, it is likely to go to the next support level at $8.89. Now, if the price goes above the second support level, the third support stands at $7.76.
Tyra Biosciences Inc (NASDAQ: TYRA) Key Stats
Market capitalization of the company is 514.13 million based on 50,603K outstanding shares. Right now, sales total 0 K and income totals -69,130 K. The company made 0 K in profit during its latest quarter, and -24,020 K in sales during its previous quarter.
